NorthStar Medical Technologies and NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, announced recently a long-term strategic partnership under which NorthStar will produce Copper-67 (Cu-67) and provide comprehensive radiopharmaceutical manufacturing services to…

NorthStar Medical Technologies is partnering with Quarkmed, a Beijing-based contract research organization (CRO) specializing in nuclear medicine and radiopharmaceutical clinical development, the company announced today. According to a release, Quarkmed…

NorthStar Medical Technologies announced today a multi-year growth capital facility of up to $185 million from Hercules Capital for continued growth and expansion. According to a release, the financing will…

NorthStar Medical Technologies promoted Dr. Frank Scholz as its new President and Chief Operating Officer, the organization announced recently. “I want to congratulate Frank Scholz on this well-deserved promotion to…

NorthStar Medical Technologies has closed $100 million in secured financing, the company announced recently. According to a release, the funds were managed by Oberland Capital Management, and the money will…